Viral hepatitis in continuous ambulatory peritoneal dialysis patients in an endemic area for hepatitis b and c infection: The taiwan experience

Blood Purification

Volumn 15, Issue 3, 1997, Pages 195-199

  Hung, Kuan Yu ^a   Shyu, Ren Shi ^a   Huang, Ching Huai ^a   Tsai, Tun Jun ^a   Chen, Wan Yu ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Continuous ambulatory peritoneal dialysis; Hepatitis B virus; Hepatitis C virus

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS C ANTIBODY;

ADULT; ARTICLE; BLOOD TRANSFUSION; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; ENDEMIC DISEASE; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEROPREVALENCE; TAIWAN;

ADOLESCENT; ADULT; AGED; BLOOD TRANSFUSION; COMORBIDITY; FEMALE; HEPATITIS B; HEPATITIS C; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; PREVALENCE; RENAL DIALYSIS; TAIWAN;

EID: 0030849121     PISSN: 02535068     EISSN: 14219735     Source Type: Journal    
DOI: 10.1159/000170332     Document Type: Article

References (13)

1. Pelrosillo N, Puro V, Ippolito G: Prevalence of human immunodeficiency virus, hepatitis B virus and hepatitis C virus among dialysis patients. The Italian mullicentric study on nosocomial and occupational risk of blood-borne infections in dialysis. Nephron 1993:64:636- 639.
2. Mazzoni A, Innocenti M, Consaga M: Retrospective study on the prevalence of B and non-A. non-B hepatitis in a dialysis unit: 17-year follow-up. Nephron 1992;61:316-317.
3. Sheu JC, Lee SH, Wang JT, Shih LN. Wang TH. Chen DS: Prevalence of anti-HCV and HCV vire-mia in hemodialysis patients in Taiwan. J Med Virol 1992:37:108-112.
4. Lin DY, Lin HH, Hunan CC, Liaw YF: High incidence of hepatitis C virus infection in hemodialysis patients in Taiwan. Am J Kidney Dis 1993:21:288-291.
5. Sun JL. Chen DS. Lai MY. ct al: Epidemiological study on hepatitis B virus infection in Taiwan. Chin J Gastroenterol 1984:1:1-9.
6. Sheu JC, Wang JT, Wang TH, et al: Prevalence of hepatitis C viral infection in a community in Taiwan. J Hepatol 1993;17:192-198.
7. Lin-Chu M. Tasi SJL. Watanabc J. Nishioka K: The prevalence of anti-HCV among Chinese voluntary blood donors in Taiwan. Transfusion 1990:30:471-473.
8. Hung KY. Chen WY, Yang CS. Lee SH, Wu DJ: Hepatitis B and C in hemodialysis patients. Dial Transplant 1995;24:135-139.
9. Elisaf' M. Tsianos E, Mavridis A, Dardamanis M. Pappas M. Siamo-poulos KC: Antibodies against hepatitis C virus (anti-HCV) in hemodialysis patients: Association with hepatitis B serological markers. Nephrol Dial Transplant 1991:6: 476-479.
10. Ng YY, Lee SD, Wu SC, Yang WC, Chaing SS, Huang TP: Antibodies to hepatitis C virus in uremic patients on continuous ambulatory peritoneal dialysis. J Med Virol 1991;35: 263-266.
11. Hung CC, Wu MS, Lin DY: The prevalence of hepatitis C virus antibodies in patients treated with continuous ambulatory peritoneal dialysis. Perit Dial Int 1992;12:31-33.
12. Gladziwa U. Schlipkotcr U. Lorbccr B. Cholmakow K. Roggendorf M. Sicbcrth HG: Prevalence of antibodies to hepatitis C virus in pa-tientson peritoneal dialysis - A multicenter study. Clin Nephrol 1993: 40:46-52.
13. Kraulzig S, Tillmann H, Wrenger E, Manns M, Koch KM, Brunkhorst R: Hepatitis C virus in peritoneal dialysis. Clin Nephrol 1994:41:120.